Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Translocación macular para la degeneración macular neovascular senil

Información

DOI:
https://doi.org/10.1002/14651858.CD006928.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 octubre 2008see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Salud ocular y de la visión

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Chiara M Eandi

    Correspondencia a: Department of Clinical Physiopathology, Eye Clinic, University of Torino, Torino, Italy

    [email protected]

  • Fabrizio Giansanti

    Department of Neuro‐Oto‐Ophthalmological Surgical Sciences, Eye Clinic, University of Florence, Florence, Italy

  • Gianni Virgili

    Department of Neuro‐Oto‐Ophthalmological Surgical Sciences, Eye Clinic, University of Florence, Florence, Italy

Contributions of authors

Conceiving the review: CE, FG, GV
Designing the review: CE, FG, GV
Co‐ordinating the review: CE
Data collection for the review
‐ Designing electronic search strategies: CEVG editorial base
‐ Undertaking manual searches: CE
‐ Screening search results: CE, FG
‐ Organising retrieval of papers: CE
‐ Screening retrieved papers against inclusion criteria: CE, FG, GV
‐ Appraising quality of papers: CE, FG, GV
‐ Extracting data from papers: CE, FG
‐ Writing to authors of papers for additional information: CE
‐ Providing additional data about papers: CE
‐ Obtaining and screening data on unpublished studies: CE
‐Data management for the review
‐ Entering data into RevMan: CE, GV
Analysis of data: CE, GV
Interpretation of data
‐ Providing a methodological perspective: GV
‐ Providing a clinical perspective: CE, FG, GV
‐ Providing a policy perspective: CE, FG, GV
Writing the review: CE, FG, GV
Providing general advice on the review: GV
Securing funding for the review: CE

Sources of support

Internal sources

  • University of Torino, Italy.

  • University of Florence, Italy.

External sources

  • No sources of support supplied

Declarations of interest

Chiara Eandi: grants for participation at meetings from Novartis.
Fabrizio Giansanti: grants for participation at meetings from Allergan, Novartis and Pfizer.
Gianni Virgili: grants for participation at meetings from Allergan, Novartis and Pfizer; paid participation in advisory boards for Novartis and Pfizer.

Acknowledgements

We acknowledge the Trials Search Co‐ordinator for Cochrane Eyes and Vision Group (CEVG), for devising and running the electronic searches. We thank Anupa Shah, Review Group Co‐ordinator for CEVG and the peer referees including Catey Bunce and Francesca Menchini for their assistance and comments, Jennifer Evans for her editorial support. We would also like to thank the following members of the CEVG Consumer Panel for their comments on the abstract and plain language summary of this review: Harold Burton, Bill Crowther, Peter Dyson, Jan Elson, Diana Fitchett, Oliver Keene, Brenda Rogers, Bob Thomas, David Yule.

Version history

Published

Title

Stage

Authors

Version

2008 Oct 08

Macular translocation for neovascular age‐related macular degeneration

Review

Chiara M Eandi, Fabrizio Giansanti, Gianni Virgili

https://doi.org/10.1002/14651858.CD006928.pub2

2008 Jan 23

Macular translocation for age‐related macular degeneration

Protocol

Chiara M Eandi, Fabrizio Giansanti, Gianni Virgili

https://doi.org/10.1002/14651858.CD006928

Differences between protocol and review

Risk of bias table used to judge methodological quality for each study included in the review.